Immune checkpoint inhibitors in chronic hepatitis B: therapy or high-risk factor for reactivation?

Cai, C; Zhang, HF; Yang, NB; Lu, MQ

Lu, MQ (通讯作者)，Wenzhou Med Univ, Affiliated Hosp 1, Dept Infect Dis, Wenzhou 325000, Zhejiang, Peoples R China.

HEPATOLOGY INTERNATIONAL, 2022; 16 (2): 480

Abstract

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索